Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 532.6 Million CNY | -11.94% |
| 2022 | 604.8 Million CNY | 517.73% |
| 2021 | -144.78 Million CNY | -120.49% |
| 2020 | 706.58 Million CNY | -51.89% |
| 2019 | 1.46 Billion CNY | 12.67% |
| 2018 | 1.3 Billion CNY | 32.81% |
| 2017 | 981.37 Million CNY | 10.08% |
| 2016 | 891.53 Million CNY | 18.16% |
| 2015 | 754.52 Million CNY | 24.61% |
| 2014 | 605.52 Million CNY | 95.02% |
| 2013 | 310.49 Million CNY | 83.69% |
| 2012 | 169.03 Million CNY | 11.48% |
| 2011 | 151.62 Million CNY | 11.4% |
| 2010 | 136.1 Million CNY | 10.16% |
| 2009 | 123.54 Million CNY | 98.98% |
| 2008 | 62.08 Million CNY | 5.27% |
| 2007 | 58.98 Million CNY | -27.1% |
| 2006 | 80.91 Million CNY | -10.26% |
| 2005 | 90.16 Million CNY | 25.51% |
| 2004 | 71.83 Million CNY | 68.73% |
| 2003 | 42.57 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 193.91 Million CNY | 1.36% |
| 2024 Q2 | 193.91 Million CNY | 0.0% |
| 2023 Q4 | 191.31 Million CNY | 0.0% |
| 2023 FY | 532.6 Million CNY | -11.94% |
| 2023 Q1 | 74.98 Million CNY | -51.28% |
| 2023 Q2 | 74.98 Million CNY | 0.0% |
| 2023 Q3 | 191.31 Million CNY | 155.12% |
| 2022 Q2 | 148.49 Million CNY | 0.0% |
| 2022 Q3 | 153.9 Million CNY | 3.64% |
| 2022 Q4 | 153.9 Million CNY | 0.0% |
| 2022 FY | 604.8 Million CNY | 517.73% |
| 2022 Q1 | 148.49 Million CNY | 157.01% |
| 2021 Q2 | 193.29 Million CNY | 0.0% |
| 2021 Q3 | -260.48 Million CNY | -234.76% |
| 2021 FY | -144.78 Million CNY | -120.49% |
| 2021 Q1 | 193.29 Million CNY | 131.25% |
| 2021 Q4 | -260.48 Million CNY | 0.0% |
| 2020 Q3 | 83.58 Million CNY | -69.01% |
| 2020 FY | 706.58 Million CNY | -51.89% |
| 2020 Q2 | 269.7 Million CNY | 0.0% |
| 2020 Q1 | 269.7 Million CNY | -18.88% |
| 2020 Q4 | 83.58 Million CNY | 0.0% |
| 2019 Q3 | 332.46 Million CNY | -9.07% |
| 2019 FY | 1.46 Billion CNY | 12.67% |
| 2019 Q4 | 332.46 Million CNY | 0.0% |
| 2019 Q1 | 365.62 Million CNY | -1.25% |
| 2019 Q2 | 365.62 Million CNY | 0.0% |
| 2018 Q1 | 281.43 Million CNY | -5.56% |
| 2018 Q3 | 370.24 Million CNY | 31.55% |
| 2018 Q4 | 370.24 Million CNY | 0.0% |
| 2018 FY | 1.3 Billion CNY | 32.81% |
| 2018 Q2 | 281.43 Million CNY | 0.0% |
| 2017 Q4 | 297.99 Million CNY | 0.0% |
| 2017 Q3 | 297.99 Million CNY | 54.65% |
| 2017 Q2 | 192.68 Million CNY | 0.0% |
| 2017 Q1 | 192.68 Million CNY | -17.47% |
| 2017 FY | 981.37 Million CNY | 10.08% |
| 2016 Q3 | 233.48 Million CNY | 9.99% |
| 2016 FY | 891.53 Million CNY | 18.16% |
| 2016 Q4 | 233.48 Million CNY | 0.0% |
| 2016 Q2 | 212.28 Million CNY | 0.0% |
| 2016 Q1 | 212.28 Million CNY | 15.03% |
| 2015 Q2 | 192.71 Million CNY | 0.0% |
| 2015 Q3 | 184.54 Million CNY | -4.24% |
| 2015 Q4 | 184.54 Million CNY | 0.0% |
| 2015 Q1 | 192.71 Million CNY | 18.83% |
| 2015 FY | 754.52 Million CNY | 24.61% |
| 2014 Q2 | 140.58 Million CNY | 0.0% |
| 2014 Q4 | 162.18 Million CNY | 0.0% |
| 2014 FY | 605.52 Million CNY | 95.02% |
| 2014 Q1 | 140.58 Million CNY | 55.86% |
| 2014 Q3 | 162.18 Million CNY | 15.37% |
| 2013 Q1 | 65.05 Million CNY | 0.0% |
| 2013 Q3 | 90.19 Million CNY | 38.65% |
| 2013 FY | 310.49 Million CNY | 83.69% |
| 2013 Q4 | 90.19 Million CNY | 0.0% |
| 2013 Q2 | 65.05 Million CNY | 0.0% |
| 2012 FY | 169.03 Million CNY | 11.48% |
| 2012 Q2 | 47.06 Million CNY | 16.02% |
| 2012 Q1 | 40.56 Million CNY | -25.18% |
| 2011 Q2 | 30.53 Million CNY | 11.42% |
| 2011 Q1 | 27.4 Million CNY | 534.92% |
| 2011 FY | 151.62 Million CNY | 11.4% |
| 2011 Q4 | 54.21 Million CNY | 37.37% |
| 2011 Q3 | 39.47 Million CNY | 29.27% |
| 2010 FY | 136.1 Million CNY | 10.16% |
| 2010 Q1 | 40.9 Million CNY | 66.77% |
| 2010 Q3 | 41.91 Million CNY | -14.41% |
| 2010 Q4 | 4.31 Million CNY | -89.7% |
| 2010 Q2 | 48.96 Million CNY | 19.71% |
| 2009 Q1 | 25.47 Million CNY | 0.0% |
| 2009 Q2 | 33.64 Million CNY | 32.1% |
| 2009 Q4 | 24.52 Million CNY | -38.52% |
| 2009 FY | 123.54 Million CNY | 98.98% |
| 2009 Q3 | 39.89 Million CNY | 18.57% |
| 2008 FY | 62.08 Million CNY | 5.27% |
| 2007 FY | 58.98 Million CNY | -27.1% |
| 2006 FY | 80.91 Million CNY | -10.26% |
| 2005 FY | 90.16 Million CNY | 25.51% |
| 2004 FY | 71.83 Million CNY | 68.73% |
| 2003 FY | 42.57 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 5.87 Billion HKD | 90.932% |